FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2351-2353 November 25, 2004 Number 22

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Peter M. Mauch, James O. Armitage, Bertrand Coiffier, Riccardo Dalla-Favera, and Nancy Lee Harris. Philadelphia, Lippincott Williams & Wilkins, 2004. $189. ISBN 0-7817-3526-2.

Consistency is the last refuge of the unimaginative.

— Oscar Wilde

Astonishing progress has been made over the past few years in our understanding of the pathogenesis and biology of non-Hodgkin's lymphomas, and many new and effective treatments for these tumors have become available — more than for almost any other form of cancer.

There are at least 30 different entities referred to as non-Hodgkin's lymphomas, and they range from the indolent to the very aggressive. Taken together, the non-Hodgkin's lymphomas are the fifth most common cancers in the United States and the fifth leading cause of death due to . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.